AC3 - DISCORDANT DESIGNATIONS OF BREAKTHROUGH DRUG INNOVATION- FRANCE VERSUS THE UNITED STATES
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.005
https://www.valueinhealthjournal.com/article/S1098-3015(18)33305-9/fulltext
Section Title :
Section Order :
2
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33305-9&doi=10.1016/j.jval.2018.09.005